CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_5

Translational360

The largest and most comprehensive clinically-linked translational dataset

Built for organizations working on the world's most innovative therapies.

Request a demo

Leverage the industry's leading clinical data for your translational research

Your priority
How we deliver impact
Ensure projects aren't delayed by incomplete clinical data
Guaranteed clinical history including deeply validated mortality data.
Acquire a translational data set that has sufficient clinical AND biological depth
100+ curated clinical variables in our dataset, and multiple best-in-breed molecular diagnostics options.
Tailoring your dataset to meet your projects needs
License single tumors or pan-tumors, and one-off licensing or subscription models.

Impact at scale

Sticky-scroll statistics that advance as visitors move down the page

Use this module for proof points that deserve a slower reveal. Each stat becomes active as the user scrolls, and the value animates with support for prefixes and suffixes.
01
0 Million

Patients

Patients represented across connected real-world data and workflow signals.

02
0 %

Success

Illustrative success rate or conversion metric using suffix formatting.

03
$ 0 Billion

Value unlocked

Use prefixes for currencies and decimal controls for more precise claims.

04
0 /7

Monitoring

Sticky steps keep each statistic in focus as the user scrolls to the next one.

0 Million

Patients

0 %

Success

$ 0 Billion

Value unlocked

0 /7

Monitoring

01 05

A true AI-ready, multimodal oncology dataset combining the best of both clinical and biological data

Data you can trust to derisk your project

Translational360 offers the highest level of clinical quality, drawing on ConcertAI's 1M person-hours spent curating clinical data. Our clinical data includes with guaranteed patient clinical history from diagnosis to death (in some cases, years before diagnosis), and deeply validated mortality data.

Built to answer the most complex questions in translational science

Translational360 is built from ConcertAI's 13M+ datalake, which includes an incredibly diverse set of patient data - including data drawn from 18+ discrete EMR systems across all 50 states. We have 100+ curated clinical variables in our dataset, and 500K of combined clinical and biological datasets in our ecosystem.

A trusted partner

You can trust Precision Explorer to deliver accurate results that are transparent and traceable. Precision Explorer is built using Cara, Concert AI's proprietary AI engine, which is trained on millions of human-curated clinical datasets consisting of petabytes of data. Any outputs of Precision Explorer can be compared directly in the interface to PubMed or other published literature.

Ways to apply Translational360

Understanding resistance and progression mechanisms

Leverage Translational360 analyze longitudinal tumor evolution across multiple lines of therapy using linked molecular profiling and clinical outcomes. Translational360 enables analysis of molecular evolution across multiple lines of therapy by combining tissue, liquid biopsy, and clinical outcomes data within a single framework.

Training AI for prognostics and predictive models

Translational360 ca be used to train machine learning models using linked genomic, transcriptomic, and clinical outcome data. Translational360 integrates molecular profiling, treatment history, and outcomes in a single dataset, and provides large-scale oncology cohorts with deep molecular annotation.

Clinical Trial Controls

Use Translational360 to identify real-world patients who match clinical trial eligibility criteria. Translational360 includes real-world patient cohorts that include molecularly characterized populations, enabling biomarker-aligned control arms and supporting regulatory-grade external comparator analyses.

Identifying new biomarkers

You can use Translational360 to explore associations between genomic alterations, transcriptomic signals, and treatment outcomes. Translational360 combines DNA mutations, RNA expression, and clinical outcomes in a single unified dataset, which supports identification of biomarkers emerging from real-world treatment exposure.

Selecting the optimal companion diagnostics pathway

Deploy Translational360 to assess biomarker prevalence across real-world oncology populations, compare outcomes, and inform companion diagnostic strategy and regulatory planning. Translational360 includes molecular data generated through clinically deployed testing platforms, and supports companion diagnostics strategy development using large, molecularly characterized patient populations.

Explore what our data can do

ConcertAI's data is used in 500+ peer-reviewed publications across multiple disciplines. 

Read our publications

Headline about high
integrity standards

Subhead about credibility stakes and standards duis aute irure dolor in reprehenderit.
Body detail about dedication to security and compliance ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.

Question

Answer

Question

Answer

Question

Answer

Request a demo

See how ConcertAI can support faster, more confident oncology decision-making.

Talk with our team about how AI, real-world data, and workflow-aligned products can support research, operations, and treatment impact.

Talk with our team

Share a few details and we will route you to the right specialist.